IGM Biosciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $412 | $516 | $1,254 | $497 |
Gross Profit | 412 | 516 | -1,022 | -1,679 |
EBITDA | -36,627 | -62,080 | -49,081 | -51,680 |
EBIT | -38,980 | -64,387 | -51,357 | -53,856 |
Net Income | -36,647 | -61,430 | -47,902 | -49,816 |
Net Change In Cash | 412 | 516 | 1,254 | 497 |
Free Cash Flow | -35,682 | -39,677 | -38,588 | -44,901 |
Cash | 26,495 | 42,875 | 67,263 | 79,498 |
Basic Shares | 60,514 | 60,657 | 60,434 | 60,114 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,679 | $2,130 | $1,069 | $366 |
Gross Profit | 2,679 | -6,147 | 1,069 | -7,724 |
EBITDA | -208,580 | -253,358 | -221,881 | -160,839 |
EBIT | -261,635 | -227,956 | -165,323 | |
Net Income | -195,795 | -246,416 | -214,248 | -160,680 |
Net Change In Cash | 2,679 | 2,130 | 1,069 | 366 |
Cost of Revenue | -107,045 | |||
Free Cash Flow | -158,848 | -204,612 | -16,059 | -137,583 |
Cash | 26,495 | 112,520 | 121,231 | 133,334 |
Basic Shares | 60,514 | 52,311 | 41,543 | 33,479 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.61 |
2024-09-30 | -$1.01 |
2024-06-30 | -$0.79 |
2024-03-31 | -$0.83 |
